These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29487821)

  • 21. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
    Virgili G; Parravano M; Menchini F; Brunetti M
    Cochrane Database Syst Rev; 2012 Dec; 12():CD007419. PubMed ID: 23235642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins for age-related macular degeneration.
    Gehlbach P; Li T; Hatef E
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD006927. PubMed ID: 27490232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.
    Virgili G; Menchini F; Murro V; Peluso E; Rosa F; Casazza G
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008081. PubMed ID: 21735421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic full-thickness macular hole (FTMH).
    Spiteri Cornish K; Lois N; Scott N; Burr J; Cook J; Boachie C; Tadayoni R; la Cour M; Christensen U; Kwok A
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009306. PubMed ID: 23740611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins for age-related macular degeneration.
    Gehlbach P; Li T; Hatef E
    Cochrane Database Syst Rev; 2015 Feb; 2(2):CD006927. PubMed ID: 25675254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.
    Chew EY; Klein ML; Ferris FL; Remaley NA; Murphy RP; Chantry K; Hoogwerf BJ; Miller D
    Arch Ophthalmol; 1996 Sep; 114(9):1079-84. PubMed ID: 8790092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrates for primary prevention of cardiovascular disease events.
    Jakob T; Nordmann AJ; Schandelmaier S; Ferreira-González I; Briel M
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009753. PubMed ID: 27849333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration.
    Yeong JL; Loveman E; Colquitt JL; Royle P; Waugh N; Lois N
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013154. PubMed ID: 33331670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperlipidemia and lipid-lowering therapy in diabetic retinopathy (DR): A bibliometric study and visualization analysis in 1993-2023.
    Tan H; Fu X; Chen Y; Wang Y; Chen D
    Heliyon; 2023 Oct; 9(10):e21109. PubMed ID: 37916126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Madsen KS; Chi Y; Metzendorf MI; Richter B; Hemmingsen B
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008558. PubMed ID: 31794067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis.
    Wang B; Wang F; Zhang Y; Zhao SH; Zhao WJ; Yan SL; Wang YG
    Lancet Diabetes Endocrinol; 2015 Apr; 3(4):263-74. PubMed ID: 25660574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007419. PubMed ID: 30325017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of diabetic retinopathy: a systematic review.
    Mohamed Q; Gillies MC; Wong TY
    JAMA; 2007 Aug; 298(8):902-16. PubMed ID: 17712074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum lipids and diabetic retinopathy: A cross-sectional study.
    Idiculla J; Nithyanandam S; Joseph M; Mohan VA; Vasu U; Sadiq M
    Indian J Endocrinol Metab; 2012 Dec; 16(Suppl 2):S492-4. PubMed ID: 23565476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin A and fish oils for preventing the progression of retinitis pigmentosa.
    Schwartz SG; Wang X; Chavis P; Kuriyan AE; Abariga SA
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD008428. PubMed ID: 32573764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes.
    Vail D; Callaway NF; Ludwig CA; Saroj N; Moshfeghi DM
    Am J Ophthalmol; 2019 Nov; 207():378-384. PubMed ID: 31194953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid-lowering agents for nephrotic syndrome.
    Kong X; Yuan H; Fan J; Li Z; Wu T; Jiang L
    Cochrane Database Syst Rev; 2013 Dec; (12):CD005425. PubMed ID: 24327265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Evolving Treatment of Diabetic Retinopathy.
    Mansour SE; Browning DJ; Wong K; Flynn HW; Bhavsar AR
    Clin Ophthalmol; 2020; 14():653-678. PubMed ID: 32184554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.